|
|
|
|
|
Topics
|
|
Glioblastoma
| Treatment | Case reports | Bevacizumab
|
|
|
|
|
|
Home
> Publications
> Topics
> Glioblastoma
>
Treatment
>
Case
reports >
Bevacizumab
|
|
|
|
|
|
Zhong W, Mao J, Wu D, Peng J, Ye W.
The
efficacy of stereotactic radiotherapy followed by bevacizumab and
temozolomide in the treatment of recurrent glioblastoma: a case
report.
Front
Pharmacol. 2024 Sep 4;15:1401000. doi:
10.3389/fphar.2024.1401000. PMID:
39295944. Case report. ˍ
|
|
|
|
**Alyasova AV, Ben Ammar AM, Zarkua VT, Rerberg AG.
A
case report of successful combined intra-arterial immunotherapy
and cytokine genetic therapy treatment in a patient with recurrent
glioblastoma.
Chin
Clin Oncol. 2024 Sep 6:cco-24-34. doi:
10.21037/cco-24-34. PMID:
39260431. Case report. ˍ
|
|
|
|
Yousefi A, Saraee E, Ghalehtaki R.
Defying
the Odds in Recurrent Glioblastoma: Complete Response following
Salvage Therapy with Bevacizumab and Irinotecan - A Case Report.
Case
Rep Oncol. 2026 Jan 7;19(1):238-247. doi:
10.1159/000549567. PMID:
41669196. Case report. ˍ
|
|
|
|
|
|
|
|
|